期刊文献+

非酒精性脂肪性肝病相关肝细胞癌的发病机制 被引量:2

Research advances in the pathogenesis of nonalcoholic fatty liver disease-related hepatocellular carcinoma
下载PDF
导出
摘要 非酒精性脂肪性肝炎/非酒精性脂肪性肝病(NASH/NAFLD)已经逐渐发展成为西方发达国家肝细胞癌(HCC)的主要病因之一。不同于经典的肝炎-肝硬化-肝癌疾病演变过程,近40%的NAFLD相关HCC可不经历肝硬化直接进展为HCC,表明其可能有不同的发病机制。阐述了关于NAFLD相关HCC发病机制的最新研究进展。 Nonalcoholic steatohepatitis(NASH)/nonalcoholic fatty liver disease(NAFLD)has gradually become one of the main causes of hepatocellular carcinoma(HCC)in Western developed countries.Different from the typical evolution process of hepatitis,liver cirrhosis,and liver cancer,nearly 40%NAFLD patients can progress into HCC without experiencing liver cirrhosis,suggesting other mechanisms may play a role in this process.This article elaborates on the latest research advances in the pathogenesis of NAFLD-related HCC.
作者 罗燕 施军平 LUO Yan;SHI Junping(Department of Translational Medicine,The Affiliated Hospital of Hangzhou Normal University,Hangzhou 310015,China;Institute for Liver Disease and Metabolism,Hangzhou Normal University,Hangzhou 310015,China)
出处 《临床肝胆病杂志》 CAS 北大核心 2020年第6期1217-1220,共4页 Journal of Clinical Hepatology
基金 国家自然科学基金(81570524) 浙江省自然科学基金(LQ17H070002) 杭州市科技计划项目(20170533B42)。
关键词 非酒精性脂肪性肝病 肝细胞 肝硬化 代谢 细胞重新编程 non-alcoholic fatty liver disease carcinoma,hepatocellular liver cirrhosis metabolism cellular reprogramming
  • 相关文献

参考文献1

二级参考文献20

  • 1Xiao-Yan Duan, Liang Qiao and Jian-Gao Fan Department of Gastroenterology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, China ,Storr Liver Unit at the Westmead Millennium Institute, the University of Sydney at Westmead Hospital, Westmead, NSW 2145, Australia.Clinical features of nonalcoholic fatty liver disease-associated hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2012,11(1):18-27. 被引量:16
  • 2Zobair M. Younossi,Maria Stepanova,Mariam Afendy,Yun Fang,Youssef Younossi,Hesham Mir,Manirath Srishord.Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008[J].Clinical Gastroenterology and Hepatology.2011(6)
  • 3Alejandro Forner,María E. Reig,Carlos Rodriguez de Lope,Jordi Bruix.Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects[J].Semin Liver Dis.2010(01)
  • 4Chia-Chi Wang,Tai-Chung Tseng,Tsung-Cheng Hsieh,Ching-Sheng Hsu,Pin-Chao Wang,Hans Hsienhong Lin,Jia-Horng Kao.Severity of fatty liver on ultrasound correlates with metabolic and cardiovascular risk[J].Kaohsiung Journal of Medical Sciences.2012(3)
  • 5Vernon G,Baranova A,Younossi Z M.Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Alimentary Pharmacology and Therapeutics . 2011
  • 6Sean F. Altekruse,Katherine A. McGlynn,Marsha E. Reichm.Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005. Japanese Journal of Clinical Oncology . 2009
  • 7S C Larsson,A Wolk.Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. British Journal of Cancer . 2007
  • 8Judith Ertle,Alexander Dechene,Jan-Peter Sowa.Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis. International Journal of Cancer . 2011
  • 9Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace[J]. Journal of Hepatology . 2012 (6)
  • 10Kohichiroh Yasui,Etsuko Hashimoto,Yasuji Komorizono,Kazuhiko Koike,Shigeki Arii,Yasuharu Imai,Toshihide Shima,Yoshihiro Kanbara,Toshiji Saibara,Takahiro Mori,Sumio Kawata,Hirofumi Uto,Shiro Takami,Yoshio Sumida,Toshinari Takamura,Miwa Kawanaka,Takeshi Okanoue.Characteristics of Patients With Nonalcoholic Steatohepatitis Who Develop Hepatocellular Carcinoma[J]. Clinical Gastroenterology and Hepatology . 2011 (5)

共引文献23

同被引文献15

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部